Moderna believes personalised cancer vaccine could be bigger than best-selling oncology drug ever

Moderna, the biotech group known for its Covid-19 jab, believes its personalised cancer vaccine, expected to win US regulatory approval next year, could be bigger than the best-selling oncology drug ever.

Detected & updated continuously · Source: Nebula